Shanghai Fosun Pharmaceutical (Group) financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
¥2.43B ¥2.99B ¥4.08B ¥3.69B ¥3.77B ¥3.87B ¥4.56B ¥6.49B ¥7.34B ¥10.00B ¥12.03B ¥12.61B ¥14.63B ¥18.53B ¥24.92B ¥28.59B ¥30.31B ¥39.01B ¥43.95B ¥41.40B ¥0.00M
GM % Gross Margin %
31.89% 30.49% 21.19% 27.06% 28.13% 32.58% 34.48% 38.65% 43.78% 44.27% 43.90% 49.82% 53.83% 58.85% 58.33% 59.57% 55.47% 47.97% 47.09% 47.54% 0.00%
OM Operating Margin
6.33% 4.80% 1.94% 4.46% 3.22% 4.22% 3.87% 5.52% 8.09% 10.78% 9.55% 11.13% 11.39% 11.91% 8.95% 8.32% 8.64% 6.53% 7.78% 2.86% 0.00%
EPS Earnings Per Share
¥0.13 ¥0.29 ¥0.20 ¥0.30 ¥0.44 ¥0.46 ¥0.58 ¥0.72 ¥0.91 ¥0.95 ¥0.83 ¥0.87 ¥1.06 ¥1.28 ¥1.49 ¥0.75 ¥0.00
Div. Dividends
¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.21 ¥0.27 ¥0.28 ¥0.32 ¥0.35 ¥0.38 ¥0.32 ¥0.39 ¥0.43 ¥0.56 ¥0.42 ¥0.27 ¥0.00
PR % Payout Ratio %
0 0 0 0.00% 0 0 0 0 47.73% 58.70% 48.28% 44.44% 38.46% 40.00% 38.55% 44.83% 40.57% 43.75% 28.19% 36.00% 0
Sha. Shares
0m 1622.3m 1824.42m 1856.66m 1856.66m 1856.66m 1904.39m 1904.39m 2240.46m 2240.46m 2311.61m 2314.08m 2414.51m 2495.06m 2563.06m 2562.9m 2562.9m 2562.9m 2562.9m 0m 2672.4m
OCF Operating Cash Flow
¥0.00M ¥188.35M ¥184.91M ¥131.48M ¥233.04M ¥261.87M ¥203.36M ¥316.65M ¥665.52M ¥1.01B ¥1.20B ¥1.62B ¥2.11B ¥2.58B ¥2.95B ¥3.22B ¥2.58B ¥3.95B ¥4.22B ¥3.41B ¥0.00M
FCF Free Cash Flow
¥0.00M ¥-34.25M ¥-81.70M ¥-78.23M ¥22.41M ¥-86.20M ¥-135.81M ¥-480.18M ¥-485.64M ¥-28.43M ¥80.77M ¥407.49M ¥188.08M ¥509.78M ¥-195.63M ¥-705.67M ¥-1848.46M ¥-926.74M ¥-1564.14M ¥3.06B ¥0.00M
FCFS Free Cash Flow Per Share
¥0.00 ¥-0.02 ¥-0.05 ¥-0.04 ¥0.01 ¥-0.05 ¥-0.07 ¥-0.25 ¥-0.25 ¥-0.01 ¥0.04 ¥0.17 ¥0.08 ¥0.17 ¥-0.09 ¥-0.29 ¥-0.72 ¥-0.40 ¥-0.64 ¥-0.72 ¥0.00